Literature DB >> 19805678

Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study.

Alice B Kornblith1, Helen Q Huang, Joan L Walker, Nick M Spirtos, Jacob Rotmensch, David Cella.   

Abstract

PURPOSE: The study's objective was to compare the quality of life (QoL) of patients with endometrial cancer undergoing surgical staging via laparoscopy versus laparotomy. PATIENTS AND METHODS: The first 802 eligible patients (laparoscopy, n = 535; laparotomy, n = 267) participated in the QoL study in a Gynecologic Oncology Group (GOG) randomized trial of laparoscopy versus laparotomy (GOG 2222). Patients completed QoL assessments at baseline; at 1, 3, and 6 weeks; and at 6 months postsurgery.
RESULTS: In an intent-to-treat analysis, laparoscopy patients reported significantly higher Functional Assessment of Cancer Therapy-General (FACT-G) scores (P = .001), better physical functioning (P = .006), better body image (BI; P < .001), less pain (P < .001) and its interference with QoL (P < .001), and an earlier resumption of normal activities (P = .003) and return to work (P = .04) over the 6-week postsurgery period, as compared with laparotomy patients. However, the differences in BI and return to work between groups were modest, and the adjusted FACT-G scores did not meet the minimally important difference (MID) between the two surgical arms over 6 weeks. By 6 months, except for better BI in laparoscopy patients (P < .001), the difference in QoL between the two surgical techniques was not statistically significant.
CONCLUSION: Although the FACT-G did not show a MID between the two surgical groups, and only modest differences in return to work and BI were found between the two groups, statistically significantly better QoL across many parameters in the laparoscopy arm at 6 weeks provides modest support for the QoL advantage of using laparoscopy to stage patients with early endometrial cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19805678      PMCID: PMC2773220          DOI: 10.1200/JCO.2009.22.3529

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  16 in total

1.  Laparoscopic vs. open colectomy in cancer patients: long-term complications, quality of life, and survival.

Authors:  Marco Braga; Matteo Frasson; Andrea Vignali; Walter Zuliani; Vittorio Civelli; Valerio Di Carlo
Journal:  Dis Colon Rectum       Date:  2005-12       Impact factor: 4.585

2.  Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.

Authors:  Jane C Weeks; Heidi Nelson; Shari Gelber; Daniel Sargent; Georgene Schroeder
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma.

Authors:  G H Eltabbakh; M I Shamonki; J M Moody; L L Garafano
Journal:  Cancer       Date:  2001-01-15       Impact factor: 6.860

4.  Cost analysis of laparoscopy versus laparotomy for early endometrial cancer.

Authors:  D R Scribner; R S Mannel; J L Walker; G A Johnson
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

5.  Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study.

Authors:  H D Homesley; G Boike; G W Spiegel
Journal:  Int J Gynecol Cancer       Date:  2004 Mar-Apr       Impact factor: 3.437

6.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

7.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

8.  Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.

Authors:  Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Gregory Spiegel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

9.  Laparoscopically assisted surgical staging (LASS) of endometrial cancer.

Authors:  J M Childers; P R Brzechffa; K D Hatch; E A Surwit
Journal:  Gynecol Oncol       Date:  1993-10       Impact factor: 5.482

Review 10.  Incisional bowel herniations after operative laparoscopy: a series of nineteen cases and review of the literature.

Authors:  G M Boike; C E Miller; N M Spirtos; L J Mercer; J M Fowler; R Summitt; J W Orr
Journal:  Am J Obstet Gynecol       Date:  1995-06       Impact factor: 8.661

View more
  58 in total

1.  Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer.

Authors:  Tae Wook Kong; Kyung Mi Lee; Ji Yoon Cheong; Woo Young Kim; Suk-Joon Chang; Seung-Chul Yoo; Jong-Hyuck Yoon; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.

Authors:  Larissa A Meyer; Alpa M Nick; Qiuling Shi; Xin Shelley Wang; Loretta Williams; Tremaine Brock; Maria D Iniesta; Kelly Rangel; Karen H Lu; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2015-01-31       Impact factor: 5.482

3.  Major clinical research advances in gynecologic cancer in 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Kidong Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

4.  Prognostic factors of work disability in sick-listed cancer survivors.

Authors:  Peter van Muijen; Saskia F A Duijts; Allard J van der Beek; Johannes R Anema
Journal:  J Cancer Surviv       Date:  2013-06-26       Impact factor: 4.442

5.  Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes.

Authors:  Kemi M Doll; Alison K Kalinowski; Anna C Snavely; Debra E Irwin; Jeannette T Bensen; Victoria L Bae-Jump; Kenneth H Kim; Linda Van Le; Daniel L Clarke-Pearson; Paola A Gehrig
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

6.  Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument.

Authors:  Thejus T Jayakrishnan; Hasan Nadeem; Ryan T Groeschl; Ben George; James P Thomas; Paul S Ritch; Kathleen K Christians; Susan Tsai; Douglas B Evans; Sam G Pappas; T Clark Gamblin; Kiran K Turaga
Journal:  HPB (Oxford)       Date:  2014-08-15       Impact factor: 3.647

7.  Diagnostic laparoscopic biopsy for intraabdominal tumors.

Authors:  Yasuo Sakamoto; Ryuichi Karashima; Satoshi Ida; Yu Imamura; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-09-12       Impact factor: 2.549

8.  Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study.

Authors:  Jeanne Carter; Helen Huang; Dana M Chase; Joan L Walker; David Cella; Lari Wenzel
Journal:  Int J Gynecol Cancer       Date:  2012-11       Impact factor: 3.437

9.  The health-related quality of life journey of gynecologic oncology surgical patients: Implications for the incorporation of patient-reported outcomes into surgical quality metrics.

Authors:  Kemi M Doll; Emma L Barber; Jeannette T Bensen; Anna C Snavely; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2016-03-18       Impact factor: 5.482

10.  Laparoscopic staging for apparent stage I epithelial ovarian cancer.

Authors:  Alexander Melamed; Nancy L Keating; Joel T Clemmer; Amy J Bregar; Jason D Wright; David M Boruta; John O Schorge; Marcela G Del Carmen; J Alejandro Rauh-Hain
Journal:  Am J Obstet Gynecol       Date:  2016-08-25       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.